{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T12:23:32Z","timestamp":1794227012566,"version":"4.9.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"S5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s00415-006-5001-3","type":"journal-article","created":{"date-parts":[[2006,9,24]],"date-time":"2006-09-24T19:40:15Z","timestamp":1159126815000},"page":"v2-v8","source":"Crossref","is-referenced-by-count":56,"title":["Epidemiology of neuroimmunological diseases"],"prefix":"10.1007","volume":"253","author":[{"given":"Peter","family":"Flachenecker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"5001_CR1","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/01.WNL.0000050461.05432.C5","volume":"60","author":"Aragones","year":"2003","unstructured":"Aragones JM, Bolibar I, Bonfill X, Bufill E, Mummany A, Alonso F, Illa I (2003) Myasthenia gravis: a higher than expected incidence in the elderly. Neurology 60(6):1024\u20131026","journal-title":"Neurology"},{"key":"5001_CR2","unstructured":"Arnason BG, Soliven B (1993) Acute inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy. WB, Saunders, Philadelphia, pp 1437\u20131497"},{"key":"5001_CR3","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.55.9.1385","volume":"55","author":"Badrising","year":"2000","unstructured":"Badrising UA, Maat-Schiemann M, van Duinen SG et al. (2000) Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology 55:1385\u20131387","journal-title":"Neurology"},{"key":"5001_CR4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00415-003-1068-2","volume":"250","author":"Busby","year":"2003","unstructured":"Busby M, Donaghy M (2003) Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients. J Neurol 250:714\u2013724","journal-title":"J Neurol"},{"key":"5001_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1468-1331.2000.00006.x","volume":"7","author":"Cheng","year":"2000","unstructured":"Cheng Q, Jiang GX, Fredrikson S (2000) Incidence of Guillain-Barr\u00e9 syndrome in Sweden 1996. Eur J Neurol 7:11\u201316","journal-title":"Eur J Neurol"},{"key":"5001_CR6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00019052-200410000-00009","volume":"17","author":"Collins","year":"2004","unstructured":"Collins MP, Periquet MI (2004) Non-systemic vasculitic neuropathy. Curr Opin Neurol 17:587\u2013598","journal-title":"Curr Opin Neurol"},{"key":"5001_CR7","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","volume":"359","author":"Compston","year":"2002","unstructured":"Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221\u20131231","journal-title":"Lancet"},{"key":"5001_CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00019052-200410000-00006","volume":"17","author":"Dalakas","year":"2004","unstructured":"Dalakas MC (2004) Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol 17:561\u2013567","journal-title":"Curr Opin Neurol"},{"key":"5001_CR9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971\u2013982","journal-title":"Lancet"},{"key":"5001_CR10","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","volume":"330","author":"Drachman","year":"1994","unstructured":"Drachman DB (1994) Myasthenia gravis. N Engl J Med 330:1797\u20131810","journal-title":"N Engl J Med"},{"key":"5001_CR11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/brain\/110.4.843","volume":"110","author":"Dyck","year":"1987","unstructured":"Dyck PJ, Benstead TJ, Conn DL et al. (1987) Nonsystemic vasculitic neuropathy. Brain 110:843\u2013853","journal-title":"Brain"},{"key":"5001_CR12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1212\/WNL.48.1.214","volume":"48","author":"Emilia-Romagna","year":"1997","unstructured":"Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology (1997) A prospective study on the incidence and prognosis of Guillain-Barr\u00e9 syndrome in Emilia-Romagna region, Italy (1992\u20131993). Neurology 48:214\u2013221","journal-title":"Neurology"},{"key":"5001_CR13","unstructured":"Flachenecker P, Zettl UK (2005) Epidemiologie. In: Schmidt RM, Hoffmann F (eds) Multiple Sklerose. Urban and Fischer, M\u00fcnchen, pp 9\u201315"},{"key":"5001_CR14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00115-005-1907-8","volume":"76","author":"Flachenecker","year":"2005","unstructured":"Flachenecker P, Zettl UK, G\u00f6tze U, Haas J, Schimrigk S, Elias W, Pette M, Eulitz M, Hennig M, Bertram J, Hollweck R, Neiss A, Daumer M, Pitschnau-Michel D, Rieckmann P (2005) MS-Register in Deutschland\u2014Design und erste Ergebnisse der Pilotphase. Nervenarzt 76:967\u2013975","journal-title":"Nervenarzt"},{"key":"5001_CR15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00019052-200110000-00009","volume":"14","author":"Govoni","year":"2001","unstructured":"Govoni V, Granieri E (2001) Epidemiology of the Guillain-Barre syndrome. Curr Opin Neurol 14:605\u2013613","journal-title":"Curr Opin Neurol"},{"key":"5001_CR16","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","volume":"292","author":"Haber","year":"2004","unstructured":"Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, Chen RT (2004) Guillain-Barre syndrome following influenza vaccination. JAMA 292:2478\u20132481","journal-title":"JAMA"},{"key":"5001_CR17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00019052-200110000-00008","volume":"14","author":"Hartung","year":"2001","unstructured":"Hartung HP, Kieseier BC, Kiefer R (2001) Progress in Guillain-Barr\u00e9 syndrome. Curr Opin Neurol 14:597\u2013604","journal-title":"Curr Opin Neurol"},{"key":"5001_CR18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.880180202","volume":"18","author":"Hartung","year":"1995","unstructured":"Hartung HP, Pollard JD, Harvey GK, Toyka KV (1995) Immunopathogenesis and treatment of the Guillain-Barr\u00e9 syndrome\u2014Part I Muscle Nerve 18:137\u2013153","journal-title":"Muscle Nerve"},{"key":"5001_CR19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s001150050559","volume":"71","author":"Hein","year":"2000","unstructured":"Hein T, Hopfenm\u00fcller W (2000) Hochrechnung der Zahl an Multiple Sklerose erkrankten Patienten in Deutschland. Nervenarzt 71:288\u2013294","journal-title":"Nervenarzt"},{"key":"5001_CR20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0733-8619(18)30100-2","volume":"12","author":"Hohlfeld","year":"1994","unstructured":"Hohlfeld R, Wekerle H (1994) The thymus in myasthenia gravis. Neurol Clin 12:331\u2013342","journal-title":"Neurol Clin"},{"key":"5001_CR21","first-page":"298","volume":"78","author":"Hovi","year":"2000","unstructured":"Hovi T, Stenvik M (2000) Surveillance of patients with acute flaccid paralysis in Finland: report of a pilot study. Bull World Health Organ 78:298\u2013304","journal-title":"Bull World Health Organ"},{"key":"5001_CR22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.1780330802","volume":"33","author":"Hunder","year":"1990","unstructured":"Hunder GG, Arend WP, Bloch DA et al. (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 33:1065\u20131067","journal-title":"Arthritis Rheum"},{"key":"5001_CR23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ,Andrassy K et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187\u2013192","journal-title":"Arthritis Rheum"},{"key":"5001_CR24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jnnp.62.5.447","volume":"62","author":"Jiang","year":"1997","unstructured":"Jiang GX, Cheng Q, Link H, de Pedro-Cuesta J (1997) Epidemiological features of Guillain-Barr\u00e9 syndrome in Sweden, 1978\u20131993. J Neurol Neurosurg Psychiatry 62:447\u2013453","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5001_CR25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/123.1.116","volume":"123","author":"Kaida","year":"2000","unstructured":"Kaida K, Kusunoki S, Kamakura K et al. (2000) Guillain-Barr\u00e9 syndrome with antibody to a ganglioside, Nacetylgalactosaminyl GD1a. Brain 123:116\u2013124","journal-title":"Brain"},{"key":"5001_CR26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev.med.53.082901.103909","volume":"53","author":"Keegan","year":"2002","unstructured":"Keegan BM, Noseworthy JH (2002) Multiple sclerosis. Annu Rev Med 53:285\u2013302","journal-title":"Annu Rev Med"},{"key":"5001_CR27","unstructured":"Kissel JT (2001) Vasculitic neuropathies. In: Gilman S (ed) MedLink Neurology. MedLink Corporation, San Diego"},{"key":"5001_CR28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.6.4.382","volume":"6","author":"Kurtzke","year":"1993","unstructured":"Kurtzke JF (1993) Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 6:382\u2013427","journal-title":"Clin Microbiol Rev"},{"key":"5001_CR29","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","volume":"339","author":"Lasky","year":"1998","unstructured":"Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, Clark S, Haber P, Stolley PD, Schonberger LB, Chen RT (1998) The Guillain-Barre syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines. N Engl J Med 339:1797\u20131802","journal-title":"N Engl J Med"},{"key":"5001_CR30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/01.wco.0000175937.31569.15","volume":"18","author":"L\u00e9ger","year":"2005","unstructured":"L\u00e9ger JM, Behin A (2005) Multifocal motor neuropathy. Curr Opin Neurol 18:567\u2013573","journal-title":"Curr Opin Neurol"},{"key":"5001_CR31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","volume":"46","author":"Lublin","year":"1996","unstructured":"Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907\u2013911","journal-title":"Neurology"},{"key":"5001_CR32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1196\/annals.1254.054","volume":"998","author":"Mantegazza","year":"2003","unstructured":"Mantegazza R, Baggi F, Antozzi C, Confalonieri P, Morandi L, Bernasconi P, Andreetta F, Simoncini O, Campanella A, Beghi E, Cornelio F (2003) Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci 998:413\u2013423","journal-title":"Ann N Y Acad Sci"},{"key":"5001_CR33","unstructured":"Martyn C (1991) The epidemiology of multiple sclerosis. In: Matthews WB (ed) McAlpines\u2019s multiple sclerosis. Churchill Livingstone, New York, pp 3\u201340"},{"key":"5001_CR34","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1212\/01.WNL.0000094316.90240.EB","volume":"61","author":"Mayr","year":"2003","unstructured":"Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M (2003) Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985\u20132000. Neurology 61:1373\u20131377","journal-title":"Neurology"},{"key":"5001_CR35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00314356","volume":"235","author":"Meyer-Rienecker","year":"1988","unstructured":"Meyer-Rienecker H, Buddenhagen F (1988) Incidence of multiple sclerosis: a periodic or stable phenomenon. J Neurol 235:241\u2013244","journal-title":"J Neurol"},{"key":"5001_CR36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1468-1331.2001.00187.x","volume":"8","author":"Mygland","year":"2001","unstructured":"Mygland A, Monstad P (2001) Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol 8:157\u2013165","journal-title":"Eur J Neurol"},{"key":"5001_CR37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00019052-200410000-00010","volume":"17","author":"Nobile-Orazio","year":"2004","unstructured":"Nobile-Orazio E (2004) IgM paraproteinaemic neuropathies. Curr Opin Neurol 17:599\u2013605","journal-title":"Curr Opin Neurol"},{"key":"5001_CR38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/01.wco.0000183115.14175.29","volume":"18","author":"Oldflors","year":"2005","unstructured":"Oldflors A, Lindberg C (2005) Diagnosis, pathogenesis and treatment of inclusion body myositis. Curr Opin Neurol 18:497\u2013503","journal-title":"Curr Opin Neurol"},{"key":"5001_CR39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/mus.10317","volume":"27","author":"Olney","year":"2003","unstructured":"Olney RK, Lewis RA, Putnam TD, Campellone RV (2003) Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 27:117\u2013121","journal-title":"Muscle Nerve"},{"key":"5001_CR40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00019052-200110000-00006","volume":"14","author":"Palace","year":"2001","unstructured":"Palace J, Vincent A, Beeson D (2001) Myasthenia gravis: diagnostic and management dilemmas. Curr Opin Neurol 14:583\u2013589","journal-title":"Curr Opin Neurol"},{"key":"5001_CR41","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<970::AID-MUS20>3.0.CO;2-I","volume":"23","author":"Phillips","year":"2000","unstructured":"Phillips BA, Zilko PJ, Mastaglia FL (2000) Prevalence of sporadic inclusion body myositis in Western Australia. Muscle Nerve 23:970\u2013972","journal-title":"Muscle Nerve"},{"key":"5001_CR42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2004-829593","volume":"24","author":"Phillips","year":"2004","unstructured":"Phillips LH (2004) The epidemiology of myasthenia gravis. Semin Neurol 24:17\u201320","journal-title":"Semin Neurol"},{"key":"5001_CR43","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)91917-6","volume":"2","author":"Pinching","year":"1976","unstructured":"Pinching AJ, Peters DK, Newsom Davis J (1976) Remission of myasthenia gravis following plasma exchange. Lancet 2:1373\u20131376","journal-title":"Lancet"},{"key":"5001_CR44","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1002\/ana.410360805","volume":"36","author":"Poser","year":"1994","unstructured":"Poser CM (1994) The epidemiology of multiple sclerosis: a general overview. Ann Neurol 36(Suppl 2):S180\u2013S193","journal-title":"Ann Neurol"},{"key":"5001_CR45","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00415-004-0278-6","volume":"251","author":"Potagas","year":"2004","unstructured":"Potagas C, Dellatolas G, Tavernarakis A, Molari H, Mourtzouhou P, Koutra H, Matikas N, Balakas N (2004) Myasthenia gravis: changes observed in a 30-years retrospective clinical study of a hospital-based population. J Neurol 251:116\u2013117","journal-title":"J Neurol"},{"key":"5001_CR46","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","volume":"333","author":"Rees","year":"1995","unstructured":"Rees JH, Soudain SE, Gregson NA, Hughes RA (1995) Campylobacter jejuni infection and Guillain-Barr\u00e9 syndrome. N Engl J Med 333:1374\u20131379","journal-title":"N Engl J Med"},{"key":"5001_CR47","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","volume":"24","author":"Saperstein","year":"2001","unstructured":"Saperstein DS, Katz JS, Amato AA, Barohn RJ (2001) Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 24:311\u2013324","journal-title":"Muscle Nerve"},{"key":"5001_CR48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","volume":"110","author":"Schonberger","year":"1979","unstructured":"Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ et al. (1979) Guillain-Barr\u00e9 syndrome following vaccination in the national influenza immunization program, United States, 1976\u20131977. Am J Epidemiol 110:105","journal-title":"Am J Epidemiol"},{"key":"5001_CR49","unstructured":"Sommer C, Heuss D, Schlotter-Weigel B, Engelhardt A, Reinhold-Keller E (2003) Diagnostik und Therapie der vaskulitischen Neuropathien und Neuropathien bei Kollagenosen. In: Diener HC, f\u00fcr die Kommission \u201eLeitlinien\u201c der Deutschen Gesellschaft f\u00fcr Neurologie (eds) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. Georg Thieme Verlag, Stuttgart New York, pp 263\u2013273"},{"key":"5001_CR50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.nmd.2004.09.006","volume":"15","author":"Teixeira","year":"2005","unstructured":"Teixeira A, Cherin P, Demoule A et al. (2005) Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies. Neuromuscul Disord 15:32\u201339","journal-title":"Neuromuscul Disord"},{"key":"5001_CR51","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","volume":"190","author":"Toyka","year":"1975","unstructured":"Toyka KV, Drachman DB, Pestronk A, Kao I (1975) Myasthenia gravis: passive transfer from man to mouse. Science 190:397\u2013399","journal-title":"Science"},{"key":"5001_CR52","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","volume":"61","author":"van der Meulen","year":"2003","unstructured":"van der Meulen MFG, Bonner M, Hoogendijk JE et al. (2003) Polymyositis: a diagnostic entity reconsidered. Neurology 61:316\u2013321","journal-title":"Neurology"},{"key":"5001_CR53","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00019052-200410000-00011","volume":"17","author":"van Doorn","year":"2004","unstructured":"van Doorn PA, Ruts L (2004) Treatment of chronic inflammatory demyelinating polyneuropathy. Curr Opin Neurol 17:607\u2013613","journal-title":"Curr Opin Neurol"},{"key":"5001_CR54","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1212\/WNL.54.3.620","volume":"54","author":"van Koningsveld","year":"2000","unstructured":"van Koningsveld R, van Doorn PA, Schmitz PIM et al. (2000) Mild forms of Guillain-Barr\u00e9 syndrome in an epidemiological survey in the Netherlands. Neurology 54:620\u2013625","journal-title":"Neurology"},{"key":"5001_CR55","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/brain\/awh222","volume":"127","author":"Viala","year":"2004","unstructured":"Viala K, Renie T, Maisonobe T et al. (2004) Follow-up and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 127:2010\u20132017","journal-title":"Brain"},{"key":"5001_CR56","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1212\/01.WNL.0000145834.17020.86","volume":"63","author":"Voermans","year":"2004","unstructured":"Voermans NC, Vaneker M, Hengstman GJ et al. (2004) Primary respiratory failure in inclusion body myositis. Neurology 63:2191\u20132192","journal-title":"Neurology"},{"key":"5001_CR57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/brain\/112.1.133","volume":"112","author":"Weinshenker","year":"1989","unstructured":"Weinshenker BG, Bass B, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC (1989) The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability. Brain 112:133\u2013146","journal-title":"Brain"},{"key":"5001_CR58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.56.2.204","volume":"56","author":"Willison","year":"1993","unstructured":"Willison HJ, Veitch J, Paterson G, Kennedy PGE (1993) Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 56:204\u2013206","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-5001-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-006-5001-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-5001-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:08:07Z","timestamp":1559070487000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-006-5001-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":58,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["5001"],"URL":"https:\/\/doi.org\/10.1007\/s00415-006-5001-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}